GNW-Adhoc: US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) ...
Original-Research: Aspermont Ltd. (von GBC AG): Buy. - from ...
GNW-Adhoc: Idorsia and Viatris enter into a significant ...
Adcore meldet weiterhin starke Performance mit Finanzergebnissen ...